Literature DB >> 1950741

Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study.

M R Knowles1, N L Church, W E Waltner, J R Yankaskas, P Gilligan, M King, L J Edwards, R W Helms, R C Boucher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1950741     DOI： 10.1007/978-1-4684-5934-0_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

Review 1.  Amiloride-sensitive sodium channels contribute to the woes of the flu.

Authors:  W B Guggino; S E Guggino
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 2.  New therapeutic approaches for cystic fibrosis lung disease.

Authors:  Jane C Davies
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

3.  The Epithelial Sodium Channel Is a Modifier of the Long-Term Nonprogressive Phenotype Associated with F508del CFTR Mutations.

Authors:  Pankaj B Agrawal; Ruobing Wang; Hongmei Lisa Li; Klaus Schmitz-Abe; Chantelle Simone-Roach; Jingxin Chen; Jiahai Shi; Tin Louie; Shaohu Sheng; Meghan C Towne; Christine F Brainson; Michael A Matthay; Carla F Kim; Michael Bamshad; Mary J Emond; Norma P Gerard; Thomas R Kleyman; Craig Gerard
Journal:  Am J Respir Cell Mol Biol       Date:  2017-12       Impact factor: 6.914

Review 4.  Sodium channel blockers for cystic fibrosis.

Authors:  Elinor F Burrows; Kevin W Southern; Peadar G Noone
Journal:  Cochrane Database Syst Rev       Date:  2014-04-09

5.  A multiple reader scoring system for Nasal Potential Difference parameters.

Authors:  George M Solomon; Bo Liu; Isabelle Sermet-Gaudelus; Isabelle Fajac; Michael Wilschanski; Francois Vermeulen; Steven M Rowe
Journal:  J Cyst Fibros       Date:  2017-04-29       Impact factor: 5.482

6.  Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.

Authors:  P G Middleton; D M Geddes; E W Alton
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

Review 7.  Does epithelial sodium channel hyperactivity contribute to cystic fibrosis lung disease?

Authors:  Carey A Hobbs; Chong Da Tan; Robert Tarran
Journal:  J Physiol       Date:  2013-07-22       Impact factor: 5.182
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.